Application of an indoleamine 2,3-dioxygenase-expressing skin substitute improves scar formation in a fibrotic animal model

Journal of Investigative Dermatology

Volumn 132, Issue 5, 2012, Pages 1501-1505

  Chavez Munoz, Claudia ^a   Hartwell, Ryan ^a   Jalili, Reza B ^a   Carr, Matthew ^a   Kilani, Ruhangiz T ^a   Jafarnejad, Seyed Mehdi ^a   Rahmani Neishabour, Elham ^a   Forouzandeh, Farshad ^a   Boyce, Steven T ^b   Ghahary, Aziz ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF CINCINNATI ACADEMIC HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; COLLAGEN TYPE 1; INDOLEAMINE 2,3 DIOXYGENASE; INTERSTITIAL COLLAGENASE;

DERMIS; EPIDERMIS; GRAFT SURVIVAL; HOST CELL; KERATINOCYTE; LETTER; NONHUMAN; PRIORITY JOURNAL; RABBIT; SCAR FORMATION; SKIN FIBROBLAST; SKIN FIBROSIS; SKIN GRAFT; TISSUE ENGINEERING; WOUND HEALING;

EID: 84859756497     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.467     Document Type: Letter

References (12)

1. Coulomb B, Friteau L, Baruch J et al. (1998) Advantage of the presence of living dermal fibroblasts within in vitro reconstructed skin for grafting in humans. Plast Reconstr Surg 101:1891-903 (Pubitemid 28262320)
2. Deitch EA, Wheelahan TM, Rose MP et al. (1983) Hypertrophic burn scars: analysis of variables. J Trauma 23:895-8 (Pubitemid 13022400)
3. Forouzandeh F, Jalili RB, Germain M et al. (2008) Skin cells, but not T cells are resistant to indoleamine 2,3-dioxygenase (IDO) expressed by allogeneic fibroblasts. Wound Repair Regen 16:379-87 (Pubitemid 351661576)
4. Ghahary A, Li Y, Tredget EE et al. (2004) Expression of indoleamine 2,3-dioxygenase in dermal fibroblasts functions as a local immunosuppressive factor. J Invest Dermatol 122:953-64 (Pubitemid 38580998)
5. Jalili RB, Forouzandeh F, Rezakhanlou AM et al. (2010) Local expression of indoleamine 2,3 dioxygenase in syngeneic fibroblasts significantly prolongs survival of an engineered three-dimensional islets allograft. Diabetes 59:2219-27
6. Li Y, Tredget EE, Ghaffari A et al. (2006) Local expression of indoleamine 2,3-dioxygenase protects engraftment of xenogeneic skin substitute. J Invest Dermatol 126:128-36 (Pubitemid 43336104)
7. Li Y, Tredget EE, Ghahary A (2004) Cell surface expression of MHC class I antigen is suppressed in indoleamine 2,3-dioxygenase genetically modified keratinocytes: implications in allogeneic skin substitute engraftment. Hum Immunol 65:114-23 (Pubitemid 38224137)
8. Morris D, Wu L, Zhao LL et al. (1997) Acute and chronic animal models for excessive dermal scarring: quantitative studies. Plast Reconstr Surg 100:674-81 (Pubitemid 27381074)
9. Munn DH, Zhou M, Attwood JT et al. (1998) Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281:1191-3 (Pubitemid 28406294)
10. Rezakhanloo AM, Habibi D, Lai A et al. (2010) Highly efficient stable expression of Indoleamine 2,3 dioxigenase gene in primary fibroblasts. Biolog Proced Online 12:9028
11. Taylor M, Feng G (1991) Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 5:2516-22 (Pubitemid 21905800)
12. Uyttenhove C, Pilotte L, Theate I et al. (2003) Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 9:1269-74 (Pubitemid 37279849)